IMAGENEBIO INC (IMA) Forecast, Price Target & Analyst Ratings

NASDAQ:IMA • US45175G2075

Current stock price

5.71 USD
-0.15 (-2.56%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IMAGENEBIO INC (IMA).

Forecast Snapshot

Consensus Price Target

Price Target
$16.32
+ 185.81% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.71
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
77.14%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$16.32
Upside
+ 185.81%
From current price of $5.71 to mean target of $16.32, Based on 7 analyst forecasts
Low
$2.02
Median
$16.32
High
$31.50

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for IMA. The average price target is 16.32 USD. This implies a price increase of 185.81% is expected in the next year compared to the current price of 5.71.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

IMA Current Analyst RatingIMA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

IMA Historical Analyst RatingsIMA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
77.14%
IMA was analyzed by 7 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about IMA.
In the previous month the buy percentage consensus was at a similar level.
IMA was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-10-24Leerink PartnersInitiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.71
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
67.10%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
49.93%

Next Earnings Summary

IMA is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.71 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
IMA revenue by date.IMA revenue by date.
9.16M
-41.36%
-100.00%		800K
-100.00%		20.705M111.1M
436.59%		226.24M
103.64%		368.65M
62.95%
EBITDA
YoY % growth
IMA ebitda by date.IMA ebitda by date.
-74.397M
-6.05%		-54.064M
27.33%		-48.052M
11.12%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
IMA ebit by date.IMA ebit by date.
-75.417M
-6.37%		-54.554M
27.66%		-48.451M
11.19%		-51.912M
-7.14%		-69.026M
-32.97%		-112.327M
-62.73%		-182.106M
-62.12%		-323.039M
-77.39%		N/AN/AN/A
Operating Margin
IMA operating margin by date.IMA operating margin by date.
-823.33%N/A-6,056.38%N/AN/AN/AN/A-1,560.20%N/AN/AN/A
EPS
YoY % growth
IMA eps by date.IMA eps by date.
-20.40
11.46%		-12.12
40.59%		-7.21
40.51%		-1.90
73.61%		-2.46
-29.32%		-3.24
-31.76%		-4.92
-51.87%		-5.89
-19.59%		-3.82
35.16%		-1.69
55.82%		1.16
168.86%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.71
67.10%		-0.82
-13.91%		-0.42
85.60%		-0.43
69.63%		-0.43
39.37%		-0.43
47.29%		-0.40
4.58%		-0.49
-12.65%		-0.55
-27.90%		-0.57
-32.36%		-0.58
-44.44%		-0.61
-25.68%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-9.515M
13.13%		-12.925M
-53.13%		-14.266M
46.36%		-15.206M
-78.81%		N/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

IMA Yearly Revenue VS EstimatesIMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2025 2030 2031 2032 2033 100M 200M 300M
IMA Yearly EPS VS EstimatesIMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -10 -20 -30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
15.74%
EPS Next 5 Year
3.42%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
138.32%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

IMAGENEBIO INC / IMA Forecast FAQ

What do analysts expect the price target to be for IMAGENEBIO INC (IMA)?

7 analysts have analysed IMA and the average price target is 16.32 USD. This implies a price increase of 185.81% is expected in the next year compared to the current price of 5.71.

Can you provide the upcoming earnings date for IMAGENEBIO INC?

IMAGENEBIO INC (IMA) will report earnings on 2026-05-06, after the market close.

Can you provide the consensus estimates for IMAGENEBIO INC next earnings?

The consensus EPS estimate for the next earnings of IMAGENEBIO INC (IMA) is -0.71 USD and the consensus revenue estimate is 0 USD.

Can you provide the analyst count for IMAGENEBIO INC stock?

The number of analysts covering IMAGENEBIO INC (IMA) is 7.